SCHEMBL5451017

SCHEMBL5451017

Cc1cccnc1NC(=O)N1CCN(c2ccc(NC(=O)Nc3ccccc3OC(F)F)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.50
P2RY1 P47900 4/20 0.49
RAB9A P51151 6/20 0.48
NPC1 O15118 5/20 0.48
MAPT P10636 2/20 0.47
TRPV1 Q8NER1 2/20 0.47
KMT2A Q03164 1/20 0.46
HTT P42858 1/20 0.45
ATM Q13315 1/20 0.45
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5466986 0.88 P2RY1 (0.51) GFERP2RY1RAB9ANPC1MAPT
SCHEMBL5453434 0.88 KMT2A (0.48) P2RY1RAB9ANPC1MAPTKMT2A
SCHEMBL5453308 0.84 GFER (0.53) GFERP2RY1RAB9ANPC1MAPT
SCHEMBL5458128 0.83 TRPV1 (0.50) GFERP2RY1RAB9ANPC1MAPT
SCHEMBL5470998 0.83 RAB9A (0.53) GFERP2RY1RAB9ANPC1MAPT
SCHEMBL5460053 0.83 GLA (0.48) P2RY1RAB9ANPC1MAPTKMT2A
SCHEMBL5465363 0.82 RAB9A (0.52) GFERP2RY1RAB9ANPC1MAPT
SCHEMBL5467463 0.82 GFER (0.51) GFERP2RY1RAB9ANPC1MAPT
SCHEMBL5467464 0.82 GFER (0.51) GFERP2RY1RAB9ANPC1MAPT
SCHEMBL5457985 0.81 NPC1 (0.50) P2RY1RAB9ANPC1MAPTTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 GFER 1367/4885P2RY1 3474/4885RAB9A 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.